Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
This antibody is covered by our Worry-Free Guarantee.

Expression of selected transporters and tight junction proteins in brain capillaries of mice exposed to bilateral renal ischemia/reperfusion injury at the protein level. Brain capillaries were isolated from frozen brains of mice exposed to bilateral renal ischemia/reperfusion injury followed by protein extraction and Western blot (A). The protein content of Bcrp (Abcg2, ATP Binding Cassette Subfamily G Member 2) (B), Glut1 (Slc2a1, Solute Carrier Family 2 Member 1) (C), Mrp4 (Abcc4, ATP Binding Cassette Subfamily C Member 4) (D), and P-gp (Mdr1, Abcb1b ATP Binding Cassette Subfamily B Member1) (E) was normalized to β-actin and is shown as average of n = 3 with standard deviations. *p < 0.05, ***p < 0.001.
Image collected and cropped by CiteAb under a CC-BY license from the following publication: Kidney Ischemia/Reperfusion Injury Induces Changes in the Drug Transporter Expression at the Blood-Brain Barrier in vivo and in vitro. Front Physiol (2020)

Effects of ischemic HK-2 and uremic toxins on efflux pumps and cellular receptor protein level in brain microvascular endothelial cells. BMECs treated as described in Figure 1 were lysed and used for protein extraction. The protein content of Mrp4 (Abcc4, ATP Binding Cassette Subfamily C Member 4), Tfrc (Transferrin Receptor), and Lrp1 (LDL Receptor Related Protein 1) was measured by Western blot (A). The protein content was normalized to β-actin and to the untreated control. The densitometric analysis is shown as an average of four independent experiments with standard deviations (B–D). One-way ANOVA with Dunnett’s or Sidak’s multiple comparison test was used to compare each treatment to the untreated control. *p < 0.05.
Image collected and cropped by CiteAb under a CC-BY license from the following publication: Kidney Ischemia/Reperfusion Injury Induces Changes in the Drug Transporter Expression at the Blood-Brain Barrier in vivo and in vitro. Front Physiol (2020)


Product Details
Alternative Name |
Multidrug resistance-associated protein 4, ABCC4 |
---|---|
Application |
ICC, IHC (FS), WB |
Application Notes |
Immunocytochemistry: cytospin preparations |
Clone |
M4I-80 |
Formulation |
Liquid. In serum free culture supernatant containing 0.7% BSA and 0.1% sodium azide. |
Host |
Rat |
Immunogen |
Recombinant human MRP4 (multidrug resistance-associated protein 4) (aa 372-431). |
Isotype |
IgG2a |
Recommendation Dilutions/Conditions |
Immunocytochemistry: Use 1:20-1:50 dilution on acetone fixed cytospin preparations.Immunohistochemistry (frozen sections): Use 1:20 dilution on acetone fixed frozen sections followed by incubation with biotin-labelled rabbit anti-rat IgG and HRP-labelled streptavidin.Western Blot: Use 1:20-1:50 dilution and HRP-anti-rat-IgG.Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. |
Species Reactivity |
Human, Mouse |
UniProt ID |
O15439 |
Worry-free Guarantee |
This antibody is covered by our Worry-Free Guarantee. |
Handling & Storage
Short Term Storage |
+4°C |
---|---|
Long Term Storage |
-20°C |
Shipping |
Blue Ice |
Regulatory Status |
RUO – Research Use Only |
---|
- Deletion of Protocadherin Gamma C3 Induces Phenotypic and Functional Changes in Brain Microvascular Endothelial Cells In Vitro.: Burek, M., Meybohm, P., et al.; Front. Pharmacol. 11, 590144 (2021), Application(s): WB, Abstract
- Optimization of an Oral Mucosa in vitro Model Based on Cell Line TR146: G.C. Lin, et al.; Tissue Barriers 21, 1748459 (2020), Application(s): WB / Reactant(s) Human, Abstract
- Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood–brain barrier model: C.J. Curtaz, et al.; Fluids Barriers CNS 17, 31 (2020), Application(s): WB, Abstract — Full Text
- Kidney Ischemia/Reperfusion Injury Induces Changes in the Drug Transporter Expression at the Blood-Brain Barrier in vivo and in vitro.: Burek, M., Burmester, S., et al.; Front. Physiol. 11, 569881 (2020), Application(s): WB / Reactant(s): Mouse, Abstract
- Increased serum bile acid concentration following low-dose chronic administration of thioacetamide in rats, as evidenced by metabolomic analysis: E.S. Jeong, et al.; Toxicol. Appl. Pharmacol. 288, 213 (2015), Application(s): Western blot , Abstract
- Functionally overlapping roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate in vivo: M.L. Vlaming et al.; Clin. Cancer Res. 15, 3084 (2009), Abstract
- Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the in vivo elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate: M.L. Vlaming et al.; Clin. Cancer Res. 14, 8152 (2008), Abstract
- Mrp4 confers resistance to topotecan and protects the brain from chemotherapy: M. Leggas, et al.; Mol. Cell. Biol. 24, 7612 (2004), Abstract
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form